BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28732748)

  • 21. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
    van de Kerkhof PCM; Loewe R; Mrowietz U; Falques M; Pau-Charles I; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):119-126. PubMed ID: 31465585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.
    Ockenfels HM; Schultewolter T; Ockenfels G; Funk R; Goos M
    Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
    Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
    Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
    Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
    J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
    Thomas K; Dietze K; Wehner R; Metz I; Tumani H; Schultheiß T; Günther C; Schäkel K; Reichmann H; Brück W; Schmitz M; Ziemssen T
    Neurol Neuroimmunol Neuroinflamm; 2014 Oct; 1(3):e33. PubMed ID: 25340085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity.
    Baumeister SH; Hölig K; Bornhäuser M; Meurer M; Rieber EP; Schäkel K
    Blood; 2007 Oct; 110(8):3078-81. PubMed ID: 17616642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens.
    Döbel T; Kunze A; Babatz J; Tränkner K; Ludwig A; Schmitz M; Enk A; Schäkel K
    Blood; 2013 May; 121(18):3609-18. PubMed ID: 23460612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
    Mager K; Wehner R; Bahr F; Oelschlägel U; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Radke J; Röllig C; Schetelig J; Thiede C; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
    Transplantation; 2012 Jun; 93(12):1270-5. PubMed ID: 22643330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Numbers of 6-sulfo LacNAc (slan) Dendritic Cells in Hand Transplant Recipients.
    Baran W; Koziol M; Woźniak Z; Banasik M; Boratyńska M; Kunze A; Schakel K
    Ann Transplant; 2015 Oct; 20():649-54. PubMed ID: 26510404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
    Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
    Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
    Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells: The driver of psoriasis.
    Wang A; Bai Y
    J Dermatol; 2020 Feb; 47(2):104-113. PubMed ID: 31833093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis.
    Wada Y; Cardinale I; Khatcherian A; Chu J; Kantor AB; Gottlieb AB; Tatsuta N; Jacobson E; Barsoum J; Krueger JG
    PLoS One; 2012; 7(4):e35069. PubMed ID: 22493730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells.
    Ghoreschi K; Brück J; Kellerer C; Deng C; Peng H; Rothfuss O; Hussain RZ; Gocke AR; Respa A; Glocova I; Valtcheva N; Alexander E; Feil S; Feil R; Schulze-Osthoff K; Rupec RA; Lovett-Racke AE; Dringen R; Racke MK; Röcken M
    J Exp Med; 2011 Oct; 208(11):2291-303. PubMed ID: 21987655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine H(4) receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity.
    Gschwandtner M; Schäkel K; Werfel T; Gutzmer R
    Immunology; 2011 Jan; 132(1):49-56. PubMed ID: 20722760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.
    Frischer JM; Reindl M; Künz B; Berger T; Schmidt S; Milford EL; Knosp E; Lassmann H; Utku N
    Mult Scler; 2014 Aug; 20(9):1171-81. PubMed ID: 24526664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.
    Alonso MN; Wong MT; Zhang AL; Winer D; Suhoski MM; Tolentino LL; Gaitan J; Davidson MG; Kung TH; Galel DM; Nadeau KC; Kim J; Utz PJ; Söderström K; Engleman EG
    Blood; 2011 Sep; 118(12):3311-20. PubMed ID: 21813450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
    Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ
    J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways.
    Reich K; Reich JLK; Falk TM; Blödorn-Schlicht N; Mrowietz U; von Kiedrowski R; Pfeiffer C; Niesmann J; Frambach Y; Warren RB
    Br J Dermatol; 2019 Oct; 181(4):859-862. PubMed ID: 30972731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.